/SKIN

SKIN Stock - The Beauty Health Company

Q: What is the analyst price target for SKIN?

Analyst price target information is not currently available for SKIN.

Q: What is SKIN's market cap?

Market capitalization information is not currently available for SKIN.

Consumer Defensive|Household & Personal Products|NASDAQ

$1.53+1.32%

+$0.02 (+1.32%) • Jan 13

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

BUY

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

100

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+35.9%upside

Target: $2.08

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for SKIN

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta1.16

52W High$2.69

52W Low$0.78

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$334.29M	$397.99M	$365.88M	$260.09M	$119.09M
Gross Profit	$182.30M	$155.11M	$248.78M	$178.54M	$67.20M
Gross Margin	54.5%	39.0%	68.0%	68.6%	56.4%
Operating Income	$-67,774,000	$-130,917,000	$-25,841,000	$-39,928,000	$-17,182,000
Net Income	$-29,098,000	$-100,116,000	$44.22M	$-378,764,000	$-29,175,000
Net Margin	-8.7%	-25.2%	12.1%	-145.6%	-24.5%
EPS	$-0.23	$-0.76	$0.30	$-3.67	$-0.85

Company Overview

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a HydraFacial Delivery System designed to elevate every part of the treatment and connects providers to the consumer's preferences to create a more personalized experience; HydraFacial Nation App, an app that allows consumers to learn about their skin health, discover treatment options, and track their treatments over time; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.

Visit Website

Earnings History & Surprises

SKIN

Beat Rate

67%

Last 15 quarters

Avg Surprise

+1132.2%

EPS vs Estimate

Beats / Misses

10/4

1 met exactly

Latest EPS

$-0.09

Q4 2025

EPS Surprise History

Q1 24

+36.4%

$-0.07vs$-0.11

Q2 24

+28.6%

$-0.10vs$-0.14

Q3 24

-100.0%

$-0.10vs$-0.05

Q4 24

-25.0%

$-0.15vs$-0.12

Q1 25

+20.0%

$-0.08vs$-0.10

Q2 25

+38.5%

$-0.08vs$-0.13

Q3 25

+150.0%

$0.03vs$-0.06

Q4 25

-12.5%

$-0.09vs$-0.08

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q2 2026	May 6, 2026	—	—	—	—
Q1 2026	Mar 11, 2026	$-0.06	—	—	—
Q4 2025	Nov 6, 2025	$-0.08	$-0.09	-12.5%	✗ MISS
Q3 2025	Aug 7, 2025	$-0.06	$0.03	+150.0%	✓ BEAT
Q2 2025	May 8, 2025	$-0.13	$-0.08	+38.5%	✓ BEAT
Q1 2025	Mar 12, 2025	$-0.10	$-0.08	+20.0%	✓ BEAT
Q4 2024	Nov 12, 2024	$-0.12	$-0.15	-25.0%	✗ MISS
Q3 2024	Aug 8, 2024	$-0.05	$-0.10	-100.0%	✗ MISS
Q2 2024	May 9, 2024	$-0.14	$-0.10	+28.6%	✓ BEAT
Q1 2024	Mar 12, 2024	$-0.11	$-0.07	+36.4%	✓ BEAT
Q4 2023	Nov 13, 2023	$0.04	$0.05	+17.6%	✓ BEAT
Q3 2023	Aug 9, 2023	$0.05	$0.07	+40.0%	✓ BEAT
Q2 2023	May 10, 2023	$-0.02	$-0.04	-80.0%	✗ MISS
Q1 2023	Feb 28, 2023	$0.06	$0.06	0.0%	= MET
Q4 2022	Dec 15, 2022	—	$0.21	—	—
Q4 2022	Dec 15, 2022	—	$0.04	—	—
Q4 2022	Dec 15, 2022	—	$-0.12	—	—
Q4 2022	Nov 8, 2022	$0.01	$0.02	+164.6%	✓ BEAT
Q4 2021	Nov 9, 2021	$-0.00	$0.01	+11211.1%	✓ BEAT
Q3 2021	Aug 10, 2021	$0.00	$0.08	+5494.4%	✓ BEAT

Frequently Asked Questions about SKIN

What is SKIN's current stock price?

The Beauty Health Company (SKIN) is currently trading at $1.53 per share. The stock has moved +1.32% today.

What is the analyst price target for SKIN?

The average analyst price target for SKIN is $2.08, based on 1 analyst.

What sector is The Beauty Health Company in?

The Beauty Health Company operates in the Consumer Defensive sector, specifically within the Household & Personal Products industry. The company is traded on the NASDAQ exchange.

What is SKIN's market cap?

The Beauty Health Company has a market capitalization of $0.20 billion, making it a small-cap company.

Does SKIN pay dividends?

No, The Beauty Health Company does not currently pay a dividend to shareholders.